vasopharm
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Friedrich-bergius-ring 15, Wuerzburg, Ba...Phone Number
+49 9313590990Website
www.vasopharm.comRevenue
$5.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About vasopharm
veriNOS pharmaceuticals B.V. is a company based in the Netherlands that specializes in the pharmaceutical industry. They focus on developing innovative solutions and products aimed at improving health outcomes. Their intended clients include healthcare providers and organizations seeking advanced pharmaceutical products. The company is committed to enhancing patient care through their offerings.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is vasopharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on vasopharm recently announced quarterly report
Check out if vasopharm is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at vasopharm
Click to see if vasopharm had a recent Job posting/layoffs
Check if vasopharm has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once vasopharm has new funding data
Product Launch: Get notified when vasopharm launches new products
Website visits: Recent activity has been detected on your website
vasopharm, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined vasopharm as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
vasopharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
vasopharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about vasopharm.
vasopharm financials insights
Gather financial insights about vasopharm, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Series F
$6.5M
2016
Private Equity
$21.8M
2019
Unspecified
$11.4M
vasopharm News & Media
vasopharm GmbH Announces Brain Glutamate Microdialysate Data from Post Hoc Analyses of Clinical Trials in Traumatic Brain Injury
Ronopterin significantly reduces glutamate levels measured in brain microdialysate from TBI patients, an important and long sought indicator of biochemical neuroprotection Combined inhibition of nitric oxide synthesis and glutamate increase expands our understanding of Ronopterin's mode...vasopharm GmbH Announces Post Hoc Analyses of Clinical Trials in Traumatic Brain Injury
WÜRZBURG, Germany, Feb. 8, 2022 /PRNewswire/ -- vasopharm GmbH ("vasopharm"), a privately-held biopharmaceutical company focusing on novel therapeutics to treat cerebrovascular diseases, today announces the combined post hoc analyses of the phase 2 (NOSTRA) and phase 3 clinical trials...vasopharm GmbH Announces Results of the NOSTRA III Traumatic Brain Injury Phase III Study
WÜRZBURG, Germany, June 3, 2021 /PRNewswire/ -- vasopharm GmbH, a privately-held biopharmaceutical company focusing on novel therapeutics for the treatment of cerebrovascular diseases, today announces that the NOSTRA III traumatic brain injury (TBI) Phase III clinical trial of ronopterin...vasopharm Announces Last Patient Last Visit in NOSTRA III Traumatic Brain Injury Clinical Trial
WÜRZBURG, Germany, July 1, 2020 /PRNewswire/ -- vasopharm GmbH, a privately held biopharmaceutical company focusing on novel therapeutics for the treatment of cerebrovascular diseases, is pleased to announce today that the Last Patient Last Visit (LPLV) in its phase 3 NOSTRA III clinical...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding vasopharm
Sign Up For FreeTo access detailed company insights
veriNOS pharmaceuticals B.V. is a company based in the Netherlands that specializes in the pharmaceutical industry. They focus on developing innovative solutions and products aimed at improving health outcomes. Their intended clients include healthcare providers and organizations seeking advanced pharmaceutical products. The company is committed to... Read More
